Dr Penny As­bell joins Ad­vi­sory Board at Wize Pharma

BioSpectrum (Asia) - - People News -

Wize Pharma, Inc., an Is­rael based clin­i­cal-stage bio­phar­ma­ceu­ti­cal com­pany, fo­cused on the treat­ment of oph­thalmic dis­or­ders, re­cently an­nounced that Dr Penny As­bell, a lead­ing key opin­ion leader in the treat­ment of dry eye syn­drome has joined the Com­pany’s Ad­vi­sory Board. As a prin­ci­pal in­ves­ti­ga­tor in count­less clin­i­cal stud­ies spon­sored by the Na­tional In­sti­tute of Health’s Na­tional Eye In­sti­tute and by in­dus­try spon­sors, Dr As­bell has par­tic­i­pated in the de­vel­op­ment of phar­ma­ceu­ti­cals that have in­cluded piv­otal treat­ments for oc­u­lar con­di­tions in­clud­ing dry eyes.

Dr As­bell is a pro­fes­sor of oph­thal­mol­ogy at the Ic­ahn School of Medicine at Mount Si­nai in New York City and is the director of the Cornea Ser­vice and Cornea Clin­i­cal and Re­search Fel­low­ships at the Mount Si­nai Hospi­tal. She es­tab­lished Mount Si­nai’s Lowen­stein Foun­da­tion Sjo­gren’s Cen­ter to pro­vide multi-spe­cialty care for pa­tients with dry eyes and as­so­ci­ated sys­temic prob­lems.

Dr As­bell has au­thored and co-au­thored hun­dreds of ar­ti­cles, au­thored 25 book chap­ters, and has pre­sented over 200 lec­tures and cour­ses. She has served on the board of di­rec­tors of the Tear Film and Oc­u­lar Sur­face So­ci­ety, the Cornea So­ci­ety, the Eye Bank for Sight Restora­tion and Pro­gram Com­mit­tee-Cornea for ARVO. She is cur­rently the Deputy Editor of Eyewiki which is spon­sored by the Amer­i­can Academy of Oph­thal­mol­ogy, Editor in Chief of ECL, the of­fi­cial jour­nal of CLAO, and Sec­tion Editor of Cornea for BMC.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.